Don’t miss the latest developments in business and finance.

Autopsy underway after botched US execution

Image
AP McAlester(US)
Last Updated : May 01 2014 | 1:10 AM IST
Officials were conducting an autopsy today on a US death row inmate who writhed, clenched his teeth and appeared to struggle before prison officials halted the execution in which Oklahoma state was using a new drug combination for the first time.
The man later died of a heart attack, and the botched execution was expected to intensify the debate over how states handle lethal injections.
The White House said the failed execution fell short of the humane standards required when the death penalty is carried out.
Oklahoma Gov. Mary Fallin called for an independent review of the state's execution protocols.
The autopsy on Clayton Lockett, 38, will include an examination of the injection sites on his arms and a toxicology report to determine what drugs were in his system, medical examiner's spokeswoman Amy Elliott said.
The autopsy in Tulsa, Oklahoma, was expected to last for several hours, Elliott said, and it could take two to four months to complete the toxicology report.

More From This Section

It is routine for the medical examiner's office to conduct an autopsy on inmates after an execution, but Lockett's death is unusual because his execution was halted before he was declared dead.
Lockett was declared unconscious 10 minutes after the first of three drugs in Oklahoma's new lethal injection combination was administered last evening. Three minutes later, he began breathing heavily, writhing, clenching his teeth and straining to lift his head off the pillow.
Officials later blamed a ruptured vein for the problems with the execution, which are likely to fuel more debate about the ability of states to administer lethal injections that meet the US Constitution's requirement they be neither cruel nor unusual punishment.
Questions about execution procedures have drawn renewed attention from defense attorneys and death penalty opponents in recent months, as several states scrambled to find new sources of execution drugs because drugmakers that oppose capital punishment many based in Europe have stopped selling to US prisons and corrections departments.

Also Read

First Published: May 01 2014 | 1:10 AM IST

Next Story